Ottawa, Ontario – March 2, 2021 – Calian Group Ltd. (“Calian” or the “Company”) (TSX: CGY) today announces that it has filed and obtained a receipt for its amended and restated short form base shelf prospectus (the “Amended and Restated Prospectus”) amending and restating its short form base shelf prospectus dated January 31, 2020 (the “Original Prospectus”) with the securities commissions in each of the provinces of Canada. The Amended and Restated Prospectus, among other things, increases the amount available under the Original Prospectus by Cdn.$100 million. A copy of the Amended and Restated Prospectus can be found on the Company’s directory on SEDAR at

The filing of the Amended and Restated Prospectus allows Calian to distribute by way of prospectus in Canada up to Cdn.$200 million of common shares, preferred shares, warrants, units, subscription receipts and debt securities, or any combination thereof, during the 25-month period following the date of the Original Prospectus. Should the Company decide to offer securities during this period, the specific terms, including the use of proceeds from any offering, will be set forth in a related prospectus supplement to the Amended and Restated Prospectus, which will be filed with the applicable Canadian securities commissions.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the qualification under the securities laws of any such jurisdiction.

About Calian

We keep the world moving forward. Calian® helps people communicate, innovate, learn and lead safe and healthy lives. Every day, our employees live our values of customer commitment, integrity, innovation, respect and teamwork to engineer reliable solutions that solve complex problems. That’s Confidence. Engineered. A stable and growing 40-year company, we are headquartered in Ottawa with offices and projects spanning North American, European and international markets. Visit to learn about innovative healthcare, communications, learning and cybersecurity solutions.

Product or service names mentioned herein may be the trademarks of their respective owners.

Media inquiries:[email protected] 613-599-8600 x 2298 Investor Relations inquiries:[email protected]


Certain information included in this press release is forward-looking and is subject to important risks and uncertainties. The results or events predicted in these statements may differ materially from actual results or events. Such statements are generally accompanied by words such as “intend”, “anticipate”, “believe”, “estimate”, “expect” or similar statements. Factors which could cause results or events to differ from current expectations include, among other things: the impact of price competition; scarce number of qualified professionals; the impact of rapid technological and market change; loss of business or credit risk with major customers; technical risks on fixed price projects; general industry and market conditions and growth rates; international growth and global economic conditions, and including currency exchange rate fluctuations; and the impact of consolidations in the business services industry. For additional information with respect to certain of these and other factors, please see the Company’s most recent annual report and other reports filed by Calian with the Ontario Securities Commission. Calian disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. No assurance can be given that actual results, performance or achievement expressed in, or implied by, forward-looking statements within this disclosure will occur, or if they do, that any benefits may be derived from them.

Calian · Head Office · 770 Palladium Drive · Ottawa · Ontario · Canada · K2V 1C8
Tel: 613.599.8600 · Fax: 613-592-3664 · General info email: [email protected]